samedan logo
 
 
 
spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Advertising
Simon Caplan

Editorial
Will Brown

We're also on Twitter! Follow us @PMPSmag   

 


Click here to view the digital version of PMPS

   

 

 


Click here to view the digital version

   

 

pmps
 
 
Featured in this issue
Cold Chain Challenges
Cold Chain Challenges

The Vital Role of Cold Chain Technology

The impending headache caused by distributing a sub-zero vaccine around the world without any issues is certain to challenge the industry. How can cold chain technology make a difference at this crucial time?
New Methods in Pharma Manufacturing
New Methods in Pharma Manufacturing

Five Ways to De-Risk New Product Launches

How can virtual pharmaceutical operations market their new products and overcome the challenges that will inevitably create barriers for their introduction?
  Talent Acquisition
Talent Acquisition

The Future of the Pharma Ecosystem Post-COVID-19

Keeping the best staff and maintaining a steady stream of graduates is not easy. Discover how talent acquisition in the pharma and life science industry is being changed by the pandemic.

spacer


Published quarterly in
February, May,
August, and November



 

 
News and Press Releases

SHIONOGI LAUNCHES FETCROJAŽ (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS


More info >>

 
White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement